Demographic, comorbidity, concurrent drug, and opioid characteristics, among L-TOT users and L-TOT discontinuers between 2009–2019. حسب Qian Cai (112039)

الموضوعات:

<i>N. parisii</i> infection is not significantly changed in <i>C. elegans</i> sphingolipid biosynthesis mutants. حسب Hala Tamim El Jarkass (16625309)

الموضوعات:

Significant gene set results from EGSEA. حسب Katherine M. Peterson (19746455)

"…The table consists of columns for Gene Set Name, Rank, P-value, adjusted P-value, the general direction (increased or decreased) of the gene expression, and Sample Day.…"

Normalized significant family changes in abundance. حسب Karley K. Mahalak (3212670)

"…<p>A) <i>Erysipelotrichaceae</i> significantly increased with CCE treatment; B) <i>Bacteroidales_unclassified</i> significantly decreased with CCE treatment; C) <i>Desulfovibrionaceae</i> significantly decreased with CCE treatment; D) <i>Rikenellaceae</i> significantly decreased with CCE treatment; E) <i>Coriobacteriaceae</i> significantly decreased with CCE treatment; F) <i>Erysipelotrichaceae</i> significantly increased with TRE treatment.…"

Analysis of the significantly different metabolomic features. حسب Bhuripit Saraphol (20855573)

"…<b>(B)</b> Volcano plot highlighting the significantly different metabolomic features. The red dots represent the features with significantly increased intensity, and the purple dots represent the features with significantly decreased intensity. …"

IRE1 depletion decreases heterochromatin, DNA, and H3K9me3 methylation, and UHRF1. حسب Iratxe Zuazo-Gaztelu (21071939)

الموضوعات:

IRE1 depletion decreases heterochromatin, DNA and H3K9me3 methylation, and UHRF1. حسب Iratxe Zuazo-Gaztelu (21071939)

الموضوعات:

Overexpression of miR-129-5p alleviated depression-like behaviors by increasing ATP content. حسب Qiaozhen Qin (13159201)

Increases in temperature for the two drill systems at different positions using different drilling procedures and feed rates. The data in bold indicate the position where the highe... حسب Marsel Ganeyev (21453399)

الموضوعات:

Distribution of the same ingredient across different IDDSI levels (Percentages and frequencies) and statistical significance analysis (Chi-square analysis). حسب Muxi Chen (9294270)

الموضوعات:

Table 1_Increased frequencies of human Th-17 CD4+ T-cells and decreased T-regulatory cells in patients with early and advanced metabolic dysfunction-associated steatotic liver dise... حسب Elżbieta Supruniuk (16736637)

Table 2_Increased frequencies of human Th-17 CD4+ T-cells and decreased T-regulatory cells in patients with early and advanced metabolic dysfunction-associated steatotic liver dise... حسب Elżbieta Supruniuk (16736637)

Loss of <i>Rab23</i> decreases ciliation in MEFs and Tbr1 + intermediate progenitors. حسب Wan Ying Leong (22075947)

Linear covariate analysis of prognostically significant metabolites. Presenting the effect sizes of metabolites that showed significant differences among prognostic groups in ICU-treated COVID-19 patients. Metabolites were included based on an F-value > 2.5 and a p-value < 0.05. Metabolites marked with a single asterisk (*) were significant in both two-way ANOVA and ASCA, whereas those marked with double asterisks (**) were significant only in two-way ANOVA. Positive effect sizes indicate an increase in metabolite concentration between the compared groups, while negative values indicate a decrease. حسب Emir Matpan (21655811)

"…Positive effect sizes indicate an increase in metabolite concentration between the compared groups, while negative values indicate a decrease.…"

Utilization of anticoagulants at eight hospitals from 2019 to 2023. حسب Wei Luo (80175)

الموضوعات:

Inpatient utilization of anticoagulants from 2019 to 2023. حسب Wei Luo (80175)

الموضوعات:

Indications for warfarin prescription in outpatients and inpatients in 2023. حسب Wei Luo (80175)

الموضوعات:

Outpatient utilization of anticoagulants from 2019 to 2023. حسب Wei Luo (80175)

الموضوعات:

DDC for four anticoagulants from 2019 to 2023. حسب Wei Luo (80175)

الموضوعات:

Utilization of anticoagulants from 2019 to 2023. حسب Wei Luo (80175)

الموضوعات: